Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06035016
Status:
RECRUITING
Last Update Posted:
2023-09-13
First Post:
2023-09-06
Brief Title:
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-06
First Submit QC Date:
September 6 2023
Study First Post Date:
2023-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-06
Last Update Post Date:
2023-09-13
Last Update Post Date Type:
ACTUAL